Donepezil in a Narrow Concentration Range Augments Control and Impaired by Beta-Amyloid Peptide Hippocampal LTP in NMDAR-Independent Manner

Adlard PA, James SA, Bush AI, Masters CL (2009) Beta-amyloid as a molecular therapeutic target in Alzheimer’s disease. Drugs Today (Barc) 45:293–304 Akaike A, Takada-Takatori Y, Kume T, Izumi Y (2010) Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of α4 and α7 receptors in neuroprotection. J Mol Neurosci 40:211–216 Arias E, Gallego-Sandin S, Villarroya M, Garcia AG, Lopez MG (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther 315:1346–1353 Chen QS, Wei WZ, Shimahara T, Xie CW (2002) Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem 77:354–371 Chittajallu R, Alford S, Collingridge GL (1998) Ca2+ and synaptic plasticity. Cell Calcium 24:3773–3785 Curras MC, Dingledine R (1992) Selectivity of amino acid transmitters acting at N-methyl-d-aspartate and amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Mol Pharmacol 41:520–526 Debanne D, Poo M–M (2010) Spike-timing dependent plasticity beyond synapse—pre- and post-synaptic plasticity of intrinsic neuronal excitability. Front Syn Neurosci 2:21. doi:10.3389/fnsyn.2010.00021 Dewachter I, Filipkowski RK, Priller C, Rise L, Neyton J, Croes S, Terwel D, Gysemansf M, Devijver H, Borghgraef P, Godauxe E, Kaczmarek L, Hermsc J, Van Leuven F (2009) Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiol Aging 30:241–256 Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current-recording from cells and cell-free membrane patches. Pflugers Arch 391:85–100 Kapai NA, Solntseva EI, Skrebitsky VG (2010) Donepezil eliminates suppressive effects of beta-amyloid peptide (1–42) on long-term potentiation in the hippocampus. Bull Exp Biol Med 149:33–36 Kato K, Hayako H, Ishihara Y, Marui S, Iwane M, Miyamoto M (1999) TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons. Neurosci Lett 260:5–8 Kenney JW, Gould TJ (2008) Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 38:101–121 Kimura M, Akasofu S, Ogura H, Sawada K (2005) Protective effect of donepezil against Abeta (1–40) neurotoxicity in rat septal neurons. Brain Res 1047:72–84 Kosasa T, Kuriya Y, Matsui K, Yamanishi Y (2000) Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer’s disease, on cholinesterase activity in rats. Eur J Pharmacol 389:173–179 Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807 Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352–357 Luo L, Chen W-H, Wang M, Zhu D-M, She J-Q, Ruan D-Y (2008) Modulation of long-term potentiation by individual subtypes of muscarinic acetylcholine receptor in the rat dentate gyrus. Hippocampus 18:989–995 Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44:5–21 Matthies H, Staak S, Krug M (1996) Fucose and fucosyllactose enhance in vitro hippocampal long-term potentiation. Brain Res 725:276–280 Meunier J, Ieni J, Maurice T (2006) The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25–35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol 149:998–1012 Molnár Z, Soós K, Lengyel I, Penke B, Szegedi V, Budai D (2004) Enhancement of NMDA responses by beta-amyloid peptides in the hippocampus in vivo. NeuroRep 15:1649–1652 Moriguchi S, Zhao X, Marszalec W, Yeh JZ, Narahashi T (2005) Modulation of N-methyl-d-aspartate receptors by donepezil in rat cortical neurons. J Pharmacol Exp Ther 315:125–135 Moriguchi S, Shioda N, Han F, Yeh JZ, Narahashi T, Fukunaga K (2009) Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation. Hippocampus 19:844–854 Nichols MR, Moss MA, Reed DK, Cratic-McDaniel S, Hoh JH, Rosenberry TL (2005) Amyloid-protofibrills differ from amyloid-aggregates induced in dilute hexafluoroisopropanol in stability and morphology. J Biol Chem 280:2471–2480 Nomura I, Kato N, Kita T, Takechi H (2005) Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons. Neurosci Lett 391:1–6 Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW (1995) Structure-activity analyses of β-amyloid peptides: contributions of the β25–35 region to aggregation and neurotoxicity. J Neurochem 64:253–265 Raymond CR, Ireland DR, Abraham WC (2003) NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus. Brain Res 968:263–272 Relkin NR (2007) Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer’s disease. Exp Rev Neurother 7:735–748 Rogers SL, Doody RS, Mohs RS, Friedhoff LT (1998) Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil study group. Arch Intern Med 158:1021–1031 Rosenmund C, Westbrook GR (1993) Rundown of N-methyl-d-aspartate channels during whole-cell recording in rat hippocampal neurons: role of Ca2+ and ATP. J Physiol 470:705–729 Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051–1058 Solntseva EI, Bukanova JV, Marchenko E, Skrebitsky VG (2007) Donepezil is a strong antagonist of voltage-gated calcium and potassium channels in molluscan neurons. Comp Biochem Physiol C 144:319–326 Standridge JB (2002) Pharmacotherapeutic approaches to the treatment of Alzheimer’s disease. Clin Ther 26:615–630 Texidó L, Martín-Satué M, Alberdi E, Solsona C, Matute C (2011) Amyloid β peptide oligomers directly activate NMDA receptors. Cell Calcium 49:184–190 Vorobjev VS (1991) Vibrodissociation of sliced mammalian nervous tissue. J Neurosci Methods 38:145–150 Vorobjev VS, Sharonova IN, Haas HL (1996) A simple perfusion system for patch-clamp studies. J Neurosci Methods 68:303–307 Vyklicky L (1993) Calcium-mediated modulation of N-methyl-d-aspartate (NMDA) responses in cultured rat hippocampal neurons. J Physiol 470:575–600 Walsh DM, Selkoe DJ (2007) A beta oligomers—a decade of discovery. J Neurochem 101:1172–1184 Welsby PJ, Rowan MJ, Anwyl R (2009) Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus. Eur J Neurosci 29:65–75 Wu J, Anwyl R, Rowan MJ (1995) Beta-amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus. NeuroRep 6:2409–2413 Ye L, Qiao JT (1999) Suppressive action produced by beta-amyloid peptide fragment 31–35 on long-term potentiation in rat hippocampus is N-methyl-d-aspartate receptor-independent: it’s offset by (−)huperzine A. Neurosci Lett 275:187–190 Yuan H, Wang WP, Feng N, Wang L, Wang XL (2011) Donepezil attenuated oxygen-glucose deprivation insult by blocking Kv2.1 potassium channels. Eur J Pharmacol 657:76–83